Data as of Apr 17
 +0.08 / +4.57%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

CorMedix, Inc. is a development stage pharmaceutical and medical device company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas. The company's products are Neutrolin CRMD003, Thixotropic Gel CRMD004, Deferiprone CRMD001 and Urine Catalytic Test CRMD002. CorMedix was founded on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
745 Route 202-206
Bridgewater New Jersey 08807
P:(908) 517-9500
Investor Relations:
(908) 517-9489



Individual stakeholders11.19%
Other institutional10.98%
Mutual fund holders1.38%

Top Executives

Randy D. MilbyCEO, Director & Head-Media Relations
Steven W. LefkowitzChief Financial Officer & Independent Director
Antony E. PfaffleVice Chairman & Secretary
William J. VanjonackVice President-Manufacturing & Quality Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.